James D. Phelan
- Pathology and Forensic Medicine top 1%
- Oncology top 5%
- Molecular Biology
- Immunology top 5%
- Genetics top 2%
- Co-authors
- Louis M. StaudtRyan M. YoungWyndham H. WilsonArthur L. ShafferGeorge W. WrightRoland SchmitzDa Wei HuangSandrine Roulland
- Topics
- Lymphoma Diagnosis and Treatment (24 papers)Chronic Lymphocytic Leukemia Research (21 papers)Immune Cell Function and Interaction (13 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
James D. Phelan
47 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Pathology and Forensic Medicine 866
- Oncology 642
- Molecular Biology 519
- Immunology 490
- Genetics 423
Countries citing papers authored by James D. Phelan
This map shows the geographic impact of James D. Phelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Phelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Phelan more than expected).
Fields of papers citing papers by James D. Phelan
This network shows the impact of papers produced by James D. Phelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Phelan. The network helps show where James D. Phelan may publish in the future.
Co-authorship network of co-authors of James D. Phelan
This figure shows the co-authorship network connecting the top 25 collaborators of James D. Phelan. A scholar is included among the top collaborators of James D. Phelan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James D. Phelan. James D. Phelan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 15 | |
| 10 | 23 | |
| 11 | 8 | |
| 12 | A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implicationsbreakdown → | 583 |
| 13 | 10 | |
| 14 | 157 | |
| 15 | 57 | |
| 16 | 18 | |
| 17 | 40 | |
| 18 | 46 | |
| 19 | 11 | |
| 20 | 35 |
About James D. Phelan
James D. Phelan is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology, having authored 51 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (24 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Immune Cell Function and Interaction (13 papers). The work is most often cited by research in Pathology and Forensic Medicine (866 citations), Genetics (423 citations) and Oncology (642 citations). James D. Phelan has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Louis M. Staudt, Ryan M. Young, Wyndham H. Wilson, Arthur L. Shaffer, George W. Wright, Roland Schmitz, Da Wei Huang, Sandrine Roulland, Olga Plotnikova and David W. Scott. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.